Literature DB >> 8627771

Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.

M Marin1, D Noël, S Valsesia-Wittman, F Brockly, M Etienne-Julan, S Russell, F L Cosset, M Piechaczyk.   

Abstract

As an approach to cell targeting by retroviruses, the lack of which constitutes one major limitation of retroviral vector technology, we engineered the Moloney murine leukemia virus ecotropic envelope glycoprotein. When inserted between amino acids 6 and 7 of the latter, a single-chain antibody fragment (ScFv) specific for human major histocompatibility complex class I molecules was shown to be able to redefine the tropism of ecotropic Moloney murine leukemia virus-derived retroviral particles by allowing infection of major histocompatibility complex class I-positive human cells. At variance with other recently described experimental systems, the type of modification adopted here allowed targeted infection in the absence of coexpressed wild-type env-encoded protein molecules. Interestingly, the chimeric ScFv-env protein also retained the ability to recognize the ecotropic receptor and allowed infection of murine cells, albeit at a reduced efficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627771      PMCID: PMC190154     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  An amino-terminal fragment of the Friend murine leukemia virus envelope glycoprotein binds the ecotropic receptor.

Authors:  J M Heard; O Danos
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.

Authors:  H R Hoogenboom; A D Griffiths; K S Johnson; D J Chiswell; P Hudson; G Winter
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

Review 4.  Man-made antibodies.

Authors:  G Winter; C Milstein
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

5.  Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli.

Authors:  E S Ward; D Güssow; A D Griffiths; P T Jones; G Winter
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

6.  Single-chain antigen-binding proteins.

Authors:  R E Bird; K D Hardman; J W Jacobson; S Johnson; B M Kaufman; S M Lee; T Lee; S H Pope; G S Riordan; M Whitlow
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

7.  Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.

Authors:  S Valsesia-Wittmann; F J Morling; B H Nilson; Y Takeuchi; S J Russell; F L Cosset
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies.

Authors:  N Rebaï; B Malissen
Journal:  Tissue Antigens       Date:  1983-08

9.  A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection.

Authors:  L M Albritton; L Tseng; D Scadden; J M Cunningham
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

10.  Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity.

Authors:  H Neda; C H Wu; G Y Wu
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

View more
  30 in total

1.  Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types.

Authors:  A L Boerger; S Snitkovsky; J A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Identification of the block in targeted retroviral-mediated gene transfer.

Authors:  Y Zhao; L Zhu; S Lee; L Li; E Chang; N W Soong; D Douer; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Antibody-directed targeting of retroviral vectors via cell surface antigens.

Authors:  K Morizono; G Bristol; Y M Xie ; S K Kung; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.

Authors:  S Snitkovsky; T M Niederman; B S Carter; R C Mulligan; J A Young
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.

Authors:  E Bachrach; M Marin; M Pelegrin; G Karavanas; M Piechaczyk
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.

Authors:  S Valsesia-Wittmann; F J Morling; T Hatziioannou; S J Russell; F L Cosset
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 7.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

8.  Retargeting vesicular stomatitis virus glycoprotein pseudotyped lentiviral vectors with enhanced stability by in situ synthesized polymer shell.

Authors:  Min Liang; Ming Yan; Yunfeng Lu; Irvin S Y Chen
Journal:  Hum Gene Ther Methods       Date:  2013-02       Impact factor: 2.396

Review 9.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

10.  The hypervariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system.

Authors:  S C Kayman; H Park; M Saxon; A Pinter
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.